BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2003
View Archived Issues
Potential new applications reported for the antidepressant milnacipran
Read More
Clinical trial assesses combination of NMDA antagonist and morphine in chronic pain
Read More
Effective analgesia induced by LAS-34475 in postoperative dental pain
Read More
Evidence of efficacy for erlosamide in neuropathic pain
Read More
Preclinical results for NeuGene agents against single-stranded RNA viruses
Read More
JUPITER assesses effect of Crestor on cardiovascular disease risk reduction
Read More
BlockAide/CR appears to target diverse HIV-1 strains
Read More
Pyrrolidine CCR5 receptor modulators identified by Merck
Read More
New P2Y agonists with utility in COPD therapy presented by Celltech
Read More
CV Therapeutics identifies adenosine A3 receptor agonists with utility in cancer and neutropenia
Read More
Celltech researchers describe hydroxamate-based MMP inhibitors
Read More
New series of analgesic NMDA glycine-site antagonists under study at Gruenenthal
Read More
Melacure claims melanocortin receptor modulators for obesity, inflammation, etc.
Read More
Roche scientists prepare and test new 5-HT6 receptor ligands
Read More
New antiparkinsonian adenosine A2A antagonists discovered at Sigma-Tau
Read More
New antibacterial macrolides in early development at Enanta
Read More
Photofrin approved in Canada for HGD associated with Barrett's esophagus
Read More
European approval for Nutropin AQ
Read More
Launch date set for Finacea
Read More
Fuzeon 48-week data reported, progressive distribution program planned
Read More
Novel analgesic from Otsuka useful for peripheral neuropathic pain
Read More
Antihyperalgesic effects determined for UCB-34714 in rat models of neuropathic pain
Read More
Hong Kong researchers succeed in isolating virus responsible for SARS
Read More
First findings supporting UCB-34714 as an improved antiepileptic agent
Read More
Italian investigators identify potent new ARIs with potential in diabetic complications
Read More